Paramed Max Strength Congestion Relief (Phenylephrine Hydrochloride)

Phenylephrine is a selective α1‑adrenergic agonist. It binds to α1 receptors on the blood vessels of the nasal mucosa, causing vasoconstriction. This narrowing of vessels reduces blood flow and edema in the nasal lining, which opens the airway and eases congestion.

The specific dose of phenylephrine for Paramed Max Strength Congestion Relief is determined by the prescribing healthcare professional based on the patient’s age, condition, and regulatory guidelines. Patients should follow the prescriber’s instructions and the product label.

Phenylephrine is classified as Category C for pregnancy in many regions, meaning risk cannot be ruled out. It should only be used if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult a healthcare provider, as small amounts may pass into breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Both phenylephrine and pseudoephedrine act as sympathomimetic decongestants, but phenylephrine has a shorter duration of action and is less likely to cause central nervous system stimulation. Pseudoephedrine generally provides more potent systemic decongestion but is more tightly regulated in many countries due to misuse potential.

Store Paramed Max Strength Congestion Relief at ambient temperature, below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly sealed until use.

The product is supplied as oral tablets intended for swallowing with water. It is taken by mouth as directed by a healthcare professional, typically after meals to reduce gastrointestinal irritation, unless otherwise instructed on the label.

Serious risks include significant elevation of blood pressure, cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients with uncontrolled hypertension, heart disease, or known hypersensitivity should avoid the product and seek immediate medical attention if serious symptoms develop.

Individuals with uncontrolled hypertension, recent myocardial infarction, severe coronary artery disease, hyperthyroidism, or known hypersensitivity to phenylephrine or any excipients should not use this product. Children under the recommended age limit should also avoid it unless a clinician advises otherwise.